Genital herpes is a recurrent lifelong disease with no cure, caused by herpes simplex virus (HSV).
HSV-2 is usually the cause but HSV-1 may occur in up to 1/3 of new cases.
HSV-1 tends to cause fewer recurrences & milder disease than HSV-2.
The incubation period is 2 days-2 weeks after exposure.
Education is the best strategy for preventing the spread of sexually transmitted infections (STIs), according to the guidelines presented at the 14th Urological Association of Asia Congress in Singapore.
Genital herpes is a prevalent disease that leads to significant morbidity and mortality worldwide. Recent studies on understanding genital herpes simplex virus (HSV) infections are included in this study.
Nucleoside analogues are generally used in the treatment of genital infections with the herpes simplex virus (HSV). Pritelivir, a new antiviral, have shown to be effective in lessening the rate of genital HSV.
The effect of acyclovir on risk of herpes simplex virus type 2 (HSV-2) transmission in partnerships in which human immunodeficiency virus type 1 (HIV-1)-susceptible partners were HSV-2 seronegative was determined in this study.
Two kinds of oral bacteria were associated with an increased risk of pancreatic cancer, according to research presented at the 2016 meeting of the American Association for Cancer Research (AACR), held recently in New Orleans, Louisiana, US.
Patients with fluoroquinolone-resistant rectal vault flora appear to have higher odds of developing infectious complications following transrectal ultrasound-guided prostate needle biopsy despite targeted prophylaxis, a study has found.
Increasing daily water intake by 1.5 L can half the risk of recurrent acute uncomplicated cystitis (rAUC) in women, suggests a study presented at the recent Infectious Disease Week (IDWeek) in San Diego, California, US.